Mayanna Lund Selected Research

Mayanna Lund Research Topics

Disease

19	Heart Failure 04/2024 - 11/2016
3	Cardiomyopathies (Cardiomyopathy) 12/2023 - 11/2016
2	Obesity 04/2024 - 01/2021
2	Atrial Fibrillation 04/2024 - 01/2019
1	Chronic Renal Insufficiency 04/2024
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 12/2023
1	Endocarditis 11/2022
1	Death (Near-Death Experience) 01/2021
1	Overweight 01/2021
1	Systolic Heart Failure 01/2021
1	COVID-19 01/2021
1	Acute Coronary Syndrome 09/2020
1	Atrial Flutter (Flutter, Atrial) 01/2019
1	Pathologic Constriction (Stenosis) 01/2003
1	Hemochromatosis (Bronze Diabetes) 01/2003
1	Hypertension (High Blood Pressure) 01/2003
1	Thrombophilia 01/2003

Drug/Important Bio-Agent (IBA)

5	omecamtiv mecarbilIBA 12/2023 - 11/2020
4	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2024 - 11/2020
3	pro-brain natriuretic peptide (1-76)IBA 04/2024 - 01/2021
3	Cardiac MyosinsIBA 01/2021 - 11/2020
2	Natriuretic PeptidesIBA 12/2023 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
1	Neprilysin (Neutral Endopeptidase)IBA 12/2023
1	Penicillins (Penicillin)FDA Link 12/2023
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2023
1	Angiotensin Receptor AntagonistsIBA 01/2023
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	SodiumIBA 01/2022
1	Troponin T (Troponin T1)IBA 01/2022
1	Dietary SodiumIBA 01/2022
1	IronIBA 12/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2020
1	Circulating MicroRNAIBA 01/2019
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2019
1	Amphetamine (Amfetamine)FDA LinkGeneric 11/2016
1	Type 1 Angiotensin ReceptorIBA 01/2003
1	factor V LeidenIBA 01/2003
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2003
1	Endothelial Protein C ReceptorIBA 01/2003
1	Fibrinogen (Factor I)FDA Link 01/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2003
1	Oxidoreductases (Dehydrogenase)IBA 01/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2003
1	Prothrombin (Factor II)IBA 01/2003
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2003
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2003
1	Integrin beta3 (GPIIIa)IBA 01/2003
1	5,6,7,8-tetrahydrofolic acid (tetrahydrofolate)IBA 01/2003

Therapy/Procedure

7	Therapeutics 02/2024 - 11/2016
1	Drug Therapy (Chemotherapy) 02/2024
1	Diet Therapy (Therapy, Diet) 01/2022
1	Secondary Prevention 09/2020
1	Electric Countershock (Cardioversion) 01/2019